𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ACK1 tyrosine kinase: Targeted inhibition to block cancer cell proliferation

✍ Scribed by Mahajan, Kiran; Mahajan, Nupam P.


Book ID
120415938
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
650 KB
Volume
338
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Breast cancer cell line proliferation bl
✍ Tanya Meyer; LiHui Xu; Jinli Chang; Edison T. Liu; Rolf J. Craven; William G. Ca πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 564 KB

## Abstract Rak is a 54 kDa protein tyrosine kinase originally isolated from breast cancer cells and expressed in epithelial cells. It resembles the protooncogene __Src__ structurally but lacks an amino‐terminal myristylation site and localizes to the nuclear and perinuclear regions of the cell. We

Targeted inhibition of the epidermal gro
✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (β€˜Iressa’), an orally a

Drug Resistance in Cancer Cells || Mecha
✍ Siddik, Zahid H.; Mehta, Kapil πŸ“‚ Article πŸ“… 2009 πŸ› Springer US 🌐 English βš– 663 KB

It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosisand 565,650individualswould die of cancer (Jemal et al. 2008).Since the vast majority of patients dying of cancer will have had anticancer therapy, both c- ventional chemotherapy and novel targeted therapy, it can